312 related articles for article (PubMed ID: 26812787)
1. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
Esteras N; Dinkova-Kostova AT; Abramov AY
Biol Chem; 2016 May; 397(5):383-400. PubMed ID: 26812787
[TBL] [Abstract][Full Text] [Related]
2. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
Dinkova-Kostova AT; Kostov RV; Kazantsev AG
FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
[TBL] [Abstract][Full Text] [Related]
3. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
Denzer I; Münch G; Friedland K
Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
5. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
6. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
8. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
9. New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.
Wilkins HM; Morris JK
Curr Pharm Des; 2017; 23(5):731-752. PubMed ID: 28034353
[TBL] [Abstract][Full Text] [Related]
10. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
11. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
12. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.
Calkins MJ; Johnson DA; Townsend JA; Vargas MR; Dowell JA; Williamson TP; Kraft AD; Lee JM; Li J; Johnson JA
Antioxid Redox Signal; 2009 Mar; 11(3):497-508. PubMed ID: 18717629
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond.
Esteras N; Abramov AY
Free Radic Biol Med; 2022 Aug; 189():136-153. PubMed ID: 35918014
[TBL] [Abstract][Full Text] [Related]
14. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage.
Sotolongo K; Ghiso J; Rostagno A
Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869
[TBL] [Abstract][Full Text] [Related]
16. The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease.
Kahroba H; Ramezani B; Maadi H; Sadeghi MR; Jaberie H; Ramezani F
Ageing Res Rev; 2021 Jan; 65():101211. PubMed ID: 33186670
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.
Ammal Kaidery N; Ahuja M; Thomas B
Mol Cell Neurosci; 2019 Dec; 101():103413. PubMed ID: 31644952
[TBL] [Abstract][Full Text] [Related]
19. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Buendia I; Michalska P; Navarro E; Gameiro I; Egea J; León R
Pharmacol Ther; 2016 Jan; 157():84-104. PubMed ID: 26617217
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
Lee DH; Gold R; Linker RA
Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
